These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 19845745

  • 1. Free insulin-like growth factor (IGF)-1 and IGF-binding proteins-2 and -3 in serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients.
    Corbo M, Lunetta C, Magni P, Dozio E, Ruscica M, Adobbati L, Silani V.
    Eur J Neurol; 2010 Mar; 17(3):398-404. PubMed ID: 19845745
    [Abstract] [Full Text] [Related]

  • 2. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients?
    Lindgren BF, Odar-Cederlöf I, Ericsson F, Brismar K.
    Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646
    [Abstract] [Full Text] [Related]

  • 3. Free insulin-like growth factor (IGF)-I and IGF binding proteins 2, 5, and 6 in spinal motor neurons in amyotrophic lateral sclerosis.
    Wilczak N, de Vos RA, De Keyser J.
    Lancet; 2003 Mar 22; 361(9362):1007-11. PubMed ID: 12660059
    [Abstract] [Full Text] [Related]

  • 4. Circulating insulin-like growth factors and related binding proteins are selectively altered in amyotrophic lateral sclerosis and multiple sclerosis.
    Hosback S, Hardiman O, Nolan CM, Doyle MA, Gorman G, Lynch C, O'Toole O, Jakeman P.
    Growth Horm IGF Res; 2007 Dec 22; 17(6):472-9. PubMed ID: 17697791
    [Abstract] [Full Text] [Related]

  • 5. The GH-IGF system in amyotrophic lateral sclerosis: correlations between pituitary GH secretion capacity, insulin-like growth factors and clinical features.
    Pellecchia MT, Pivonello R, Monsurrò MR, Trojsi F, Longo K, Piccirillo G, Pivonello C, Rocco M, Di Somma C, Colao A, Tedeschi G, Barone P.
    Eur J Neurol; 2010 May 22; 17(5):666-71. PubMed ID: 20002733
    [Abstract] [Full Text] [Related]

  • 6. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
    Aguiar-Oliveira MH, Gill MS, de A Barretto ES, Alcântara MR, Miraki-Moud F, Menezes CA, Souza AH, Martinelli CE, Pereira FA, Salvatori R, Levine MA, Shalet SM, Camacho-Hubner C, Clayton PE.
    J Clin Endocrinol Metab; 1999 Nov 22; 84(11):4118-26. PubMed ID: 10566659
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cerebrospinal fluid insulin-like growth factor-1, insulin growth factor binding protein-2 or nitric oxide are not increased in MS or ALS.
    Pirttilä T, Vanhatalo S, Turpeinen U, Riikonen R.
    Acta Neurol Scand; 2004 May 22; 109(5):337-41. PubMed ID: 15080860
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: serum levels and hepatic messenger ribonucleic acid responses in humans.
    Olivecrona H, Hilding A, Ekström C, Barle H, Nyberg B, Möller C, Delhanty PJ, Baxter RC, Angelin B, Ekström TJ, Tally M.
    J Clin Endocrinol Metab; 1999 Feb 22; 84(2):553-60. PubMed ID: 10022415
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The maternal insulin-like growth factor (IGF) and IGF-binding protein response to trisomic pregnancy during the first trimester: a possible diagnostic tool for trisomy 18 pregnancies.
    Miell JP, Langford KS, Jones JS, Noble P, Westwood M, White A, Nicolaides KH.
    J Clin Endocrinol Metab; 1997 Jan 22; 82(1):287-92. PubMed ID: 8989275
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation.
    Juul A, Dalgaard P, Blum WF, Bang P, Hall K, Michaelsen KF, Müller J, Skakkebaek NE.
    J Clin Endocrinol Metab; 1995 Aug 22; 80(8):2534-42. PubMed ID: 7543116
    [Abstract] [Full Text] [Related]

  • 18. Determination of free insulin-like growth factor-I in human serum: comparison of ultrafiltration and direct immunoradiometric assay.
    Frystyk J, Ivarsen P, Støving RK, Dall R, Bek T, Hagen C, Ørskov H.
    Growth Horm IGF Res; 2001 Apr 22; 11(2):117-27. PubMed ID: 11472078
    [Abstract] [Full Text] [Related]

  • 19. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.
    Thorén M, Hilding A, Baxter RC, Degerblad M, Wivall-Helleryd IL, Hall K.
    J Clin Endocrinol Metab; 1997 Jan 22; 82(1):223-8. PubMed ID: 8989263
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.